May these plants and their histories be reminders to pay attention to current situations, near and far, and to be wary of ...
Companies like Adani Energy, Ashok Leyland, Canara Bank, Chalet Hotels, Cyient, Glenmark Life, Laurus Labs, L&T Foods, Mahindra Holidays, PNB Housing Finance, Venus Pipes, Vivanta Industries among ...
Shares of Laurus Labs Ltd. were trading with gains of as much as 6% on Friday, even after reporting another weak performance for the September quarter. Laurus Labs missed the Q2 EBITDA estimate from ...
Laurus Labs has managed to sustain its higher-highs and higher-lows trend on the weekly scale despite the recent market volatility. The medium-term chart shows that the bias at the counter is likely ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...
Stocks with long buildup in August series: Key levels to track on Voltas, Naukri and Laurus Labs as these stocks could potentially gain up to 9 per cent from present levels. 5 breakout pharma stocks: ...
In the corresponding quarter of the previous fiscal, Laurus Labs posted a net profit of ₹37 crore, the company said in a regulatory filing. The CNBC-TV18 poll had predicted a profit of ₹46 crore for ...
Related: There's More to Nutmeg Than Eggnog and Pumpkin Spice—Here's How to Use It Year Round Bay leaves come from the bay laurel tree (Laurus nobilis), native to the Mediterranean. They are aromatic ...
Read more: 14 Off-The-Wall Ingredients You Should Be Adding To Homemade Chili Bay leaves come from the laurel tree, specifically the Laurus nobilis, native to the Mediterranean and other warm climates ...
2 Annual General Meeting / Dividend- Rs 1.50 Per Share 28-Jun-18- 2 Annual General Meeting/Dividend - Rs 1.50/- Per Share 06-Jul-17- Catch latest stock market updates here. For all other news related ...
Laurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 vaccines, is likely to increase at 3-6% CAGR by 2026.